Enduring Material

Benzodiazepines: Prescribing, Tapering, and Polysubstance Use
View Activity Info
Enter Basic User Info
Create Account
View Content
Take Post Test
Done
View Activity Info
 
 
MyMichigan Health

4000 Wellness Drive
Midland, MI 48670
General Information
Thursday, July 23, 2026 - Monday, July 23, 2029
86 minutes
MyMichigan Health
Virtual Conference Room
MI Injury Prevention Center
MyMichigan Health
Objectives
  • Describe appropriate indications for the use of benzodiazepines.
  • Evaluate the risks of co-prescribing opioids and benzodiazepines (CDC Clinical Practice Guideline Recommendation 11).
  • Outline a benzodiazepine tapering plan.
Presentations and Speakers
Benzodiazepines: Prescribing, Tapering, and Polysubstance Use
  • Michael Smith, PharmD
  • Amy Vandenberg, PharmD
  • Alek Adkins, MD - Nationwide Children's Hospital
Available Credits/Points
  • MyMichigan Health designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • MyMichigan Health designates this enduring material for a maximum of 1.5 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statements
Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
Speakers:
Alek Adkins, MD, Michael Smith, PharmD, and Amy Vandenberg, PharmD have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Alek Adkins, MD has indicated the presentation may include discussion of any off-label uses of a product. Explanation Given: Potentially gabapentin for alcohol use disorder Buprenorphine & benzodiazepine co-administration
Michael Smith, PharmD has indicated the presentation may include discussion of any off-label uses of a product. Explanation Given: Acetaminophen and non-steroidal anti-inflammatory drug off-label use for dental-related pain.
Amy Vandenberg, PharmD has indicated the presentation may include discussion of any off-label uses of a product. Explanation Given: alternative treatments for anxiety (eg, prazosin, propranolol)

Planners and other Administrative Support:
Jill Fenske, MD has no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MyMichigan Health and Michigan Value Collaborative. MyMichigan Health is accredited by the Michigan State Medical Society to provide continuing medical education for physicians. MyMichigan Health designates this activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Test Information
80 %
100 %
7/30/2026
Continue to Enduring Material